Back
HFA Premium Access

Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: baseline characteristics of patients in the RESHAPE-HF2 trial

Session: Late breaking clinical trials: further analyses and baseline characteristics
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Speaker: Professor S. Anker (Berlin, DE)
Event: Heart Failure 2024

Congress Presentation

Add to my library

Like

About the speaker

Professor Stefan Anker

Charite University Hospital, Berlin (Germany)
179 presentations
16 followers

9 more presentations in this session

Effect of IV iron in patients with heart failure with preserved ejection fraction

Speaker: Professor S. von Haehling (Goettingen, DE)

Access
Slides
Video
Like
Thumbnail

Discussant review - FAIR-HFpEF

Speaker: Professor P. Kalra (Portsmouth, GB)

Access
Slides
Video
Like
Thumbnail

Semaglutide 2.4 mg and NTproBNP in obesity-related HFpEF: insights from the STEP-HFpEF programme

Speaker: Professor M. Petrie (Glasgow, GB)

Access
Slides
Video
Like
Thumbnail

Discussant review - STEP HFpEF Program

Speaker: Doctor A. Bayes Genis (Badalona, ES)

Access
Slides
Video
Like
Thumbnail

Design and baseline characteristics of REALIZE K: a placebo-controlled randomized-withdrawal trial of sodium zirconium cyclosilicate for hyperkalaemia management in patients with HF and reduced EF

Speaker: Doctor M. Kosiborod (Kansas City, US)

Access
Slides
Video
Like
Thumbnail

Access the full session

Late breaking clinical trials: further analyses and baseline characteristics

Speakers: Professor S. Anker, Professor S. von Haehling, Professor P. Kalra, Professor M. Petrie, Doctor A. Bayes Genis...
Access
Video
Like
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources